Xeno Laboratories Tirzepatide 10 mg Dual GIP/GLP-1 Research Vial

Tirzepatide is a synthetic peptide that activates two incretin receptors, GIP and GLP-1, rather than one. Its published design uses a long backbone with a fatty-acid side chain, and the side chain is what binds albumin and extends duration of action in the body. The dual affinity is why laboratory work treats it as a comparator for single-receptor agonists instead of as another version of them.

Semaglutide engages the GLP-1 receptor alone, while Tirzepatide engages the GIP receptor as well, so receptor panels and binding assays separate the two clearly. Downstream measurements such as cyclic AMP accumulation and insulin release overlap in part, which is exactly why a study runs both compounds in parallel arms rather than comparing published numbers from different laboratories and different assay conditions.

Add bacteriostatic water down the wall of the vial and swirl gently instead of shaking, since peptide solutions foam and lose structure under hard agitation. Concentration is milligrams divided by millilitres of diluent, so the unit value follows the volume chosen and the published conversion tables are calibration examples only. Store sealed powder cold and dry, and keep the mixed solution refrigerated without repeated freezing.

The molecule is licensed as a prescription medicine in several markets under another trade name, and the approved label lists gastrointestinal effects among the commonly reported ones that supervised use manages. This 10 mg vial is a separate product from the licensed medicine: it is sold as laboratory research material and carries no dosing instruction, no titration schedule and no guidance for human use.

Keep the sealed vial cold, dry and away from light, and let it reach room temperature before opening so condensation does not enter the powder. Once reconstituted, refrigerate the solution and avoid repeated freeze-thaw cycles, which are the usual route to a loss of potency. If a protocol needs several working sessions, split the solution into single-use aliquots before freezing.

The approved medicine label for this molecule lists gastrointestinal side effects as the most frequently reported, along with other warnings that prescribing clinicians monitor. That safety record belongs to supervised clinical use of the licensed product. Research material has no equivalent profile, since laboratory exposure data is not human safety data, and no dose or schedule appears on this page.

Yes, this 10 mg vial is listed with international checkout and a U.S. domestic shipping option, and every batch carries an HPLC report and a Certificate of Analysis. Orders are handled within one to two business days. Stock, pack and the current price are shown in the product block above, so check the availability line before ordering rather than assuming a dispatch time.